Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Rezolute has done well to continue to advance its lead drug from its pipeline, ersodetug. Click here to see why RZLT stock is ...

Grenova, which manufactures devices for the washing and recycling of plastic laboratory equipment, is in growth mode here and ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

On January 9, 2025, the Department of Biotechnology (DBT) called for proposals on ‘Translational research using genomeIndia ...

A new software algorithm developed at Caltech enables researchers to easily search for viruses in RNA sequence data, enabling ...

The Gloucester Marine Genomics Institute is a nonprofit on the cutting edge of marine biotechnology.

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Parkinson’s disease has always been a complex puzzle, for patients and researchers alike, with contributing factors ranging ...